Indirect measures: False negatives
4 part series [Part 3] ofMatching Accuracy Metrics |Catch up on Part 1 and Part 2By: Austin...
6 minute read
Indirect Measures: False Positives
4 part series [Part 2] ofMatching Accuracy MetricsBy: Austin Eliazar, Chief Data Scientist,...
5 minute read
How to evaluate the performance of a de-identification solution
4 part series [Part 1] ofMatching Accuracy MetricsBy: Austin Eliazar, Chief Data Scientist,...
7 minute read
Extending value long after the clinical trial with real-world data
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the pharmaceutical life cycle. We have already reviewed how RWD can accelerate the path to regulatory approval by leveraging it before a clinical trial even ...